Canadian biotech company BioAro unveils precision medicine to revolutionise healthcare in the UAE and prolong lives
BioAro will infuse resources to set up genome labs, clinics to launch precision medicine, personalised treatment to upgrade healthcare service, train medical professionals that will extend people’s health-span and longevity and make the UAE a global leader in precision medicare
Date: Dubai, UAE; Saturday, October 28, 2023
News Highlights:
- Introduction of Genomics in the UAE’s healthcare will revolutionise the industry by reducing health risks and extend the life span of people;
- BioAro is going to invest in the UAE to bring the latest breakthrough technology in Genomics, establish Genome testing labs, clinics, training and innovation centres that will drastically improve public health;
- The global genomics market is currently estimated at US$46.2 billion in 2023;
- With a compound annual growth rate of 12.4 percent, global genomics market is expected to surge to US$83.1 billion by 2028.
BioAro, the Canadian biotech powerhouse renowned for its groundbreaking strides in precision medicine, preventive healthcare, and personalised treatments, is embarking on a transformative journey into the heart of the United Arab Emirates.
Continue reading Canadian biotech company BioAro unveils precision medicine to revolutionise healthcare in the UAE and prolong lives
UAE News 24/7 